Found 60 matching trials
Allo HSCT Using RIC for Hematological Diseases
PHASE2This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Location
Masonic Cancer Center at University of Minnesota
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
PHASE2RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Location
Masonic Cancer Center at University of Minnesota
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
PHASE1The goal of this clinical research study is to learn if it is safe and feas...
Location
University of Texas MD Anderson Cancer Center
Allo HSCT Using RIC and PTCy for Hematological Diseases
PHASE2This is a Phase II study following subjects proceeding with our Institution...
Location
Masonic Cancer Center at University of Minnesota
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NAThis study is designed to test the ability to achieve donor hematopoietic e...
Location
Masonic Cancer Center, University of Minnesota
DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
PHASE2This is a Phase 2b clinical study, multicenter, randomized, open-label, ass...
Location
University of Alabama Hospital - Infectious Diseases
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
PHASE4This three-arm study will evaluate the efficacy and safety of various dosin...
Location
Multiple Locations
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
PHASE2This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Location
Masonic Cancer Center at University of Minnesota
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
PHASE3This was a Phase 3 study containing a randomized open-label superiority coh...
Location
Multiple Locations
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
PHASE4This is a multi-center, evaluator-blinded, randomized, comparative study de...
Location
University of Alabama at Birmingham